RxDoctor Payments Data

George Murakawa, MD

Dermatology · Troy, MINPI 1265422497

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $125,415 of the $191,692 with a category attached, or 65.4%. 39 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 32.3% of the total. Among dermatology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$191,692in general payments, 2019–2025

Across 1,242 payments — averaging $154.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$62K
  • Sanofi$50K
  • Galderma Laboratories, L.p.$26K
  • Sun Pharmaceutical Industries Inc.$19K
  • Novartis$5K
  • LEO Pharma Inc.$5K
  • plus $25K from 33 others
$1,093,409in research payments, 2019–2025

Across 307 payments — averaging $3561.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • UCB SA$358K
  • Janssen Research & Development, LLC$166K
  • AbbVie$127K
  • E.r. Squibb & Sons, L.L.C.$100K
  • Eli Lilly$98K
  • Pfizer$56K
  • plus $188K from 13 others

What the payments were for

  • Consulting fees$21,38411%
  • Speaking & faculty fees$125,41565%
  • Travel & lodging$6,9084%
  • Food & beverage$37,23419%
  • Education$7510%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$191,692 in reported general payments places this provider in the 95th percentile of 404 dermatology providers in Michigan.

See all dermatology providers in Michigan

Medicare billing

Part B allowed, 2024
$3,021,443
Medicare patients
1,187
Services billed
41,744

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab94$364,612
Dupixent PenDupilumab39$171,103
Cosentyx Sensoready (2 Pens)Secukinumab14$95,008
Humira(Cf) PenAdalimumab12$92,684
Acitretin54$26,909
Mycophenolate Mofetil153$13,994
Alclometasone Dipropionate254$9,375
Triamcinolone Acetonide519$7,915
Tacrolimus70$7,052
Doxycycline Ir-DrDoxycycline Monohydrate13$7,035
Mometasone Furoate333$5,930
Doxycycline Hyclate245$5,394
Azelaic Acid49$4,845
Clobetasol Propionate105$2,597
Econazole Nitrate76$2,249

Paid to pharmacies, not to this prescriber.

Other dermatology in Troy

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →